Evidence map›Paper›PMID 7659522›Full record

ArticleNucleic acids research1995

Activation of a muscle-specific enhancer by the Ski proto-oncogene.

J C Engert, S Servaes, P Sutrave, S H Hughes, N Rosenthal

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  8. Article
  9. Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling.Proceedings of the National Academy of Sciences of the United States of America · 1998
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

J C EngertCardiovascular Research Center, Massachusetts General Hospital-East, Charlestown 02129, USA.
S Servaes
P Sutrave
S H Hughes
N Rosenthal
Boston University · USCancer Research Center · USMassachusetts General Hospital · US

Funding

PROVIDE BASIC CANCER RESEARCHN01CO074101 · CO · ADVANCED BIOSCIENCE LABORATORIES, INC. · PI VANDE WOUDE, GEORGE F · 1987 to 1994
–
TRANSGENIC MOUSE MODELS OF LONGEVITYR01AG012316 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENTHAL, NADIA A · 1993 to 1998
–
DEVELOPMENT CONTROL OF MYOSIN LIGHT CHAIN GENESR01AR041926 · NIAMS · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENTHAL, NADIA A · 1993 to 1996
–
NCI NIH HHS N01-CO-74101NIAMS NIH HHS R01AR41926NIA NIH HHS R01AG12316
6 · The paper itself

Abstract

In transgenic mice, muscle-specific expression of the c-ski oncogene induces hypertrophy exclusively in a subset of fast muscle fibers. Here we report that regulatory elements from two genes expressed in fast fibers, myosin light chain 1/3 (MLC) and muscle creatine kinase (MCK), were activated when co-transfected with c-ski expression vectors in myoblasts. The expression from the MLC enhancer was reduced when the c-ski oncogene was cotransfected with MyoD into NIH3T3 fibroblasts. Activation of the MLC enhancer by Ski also occurred in vivo, since bigenic progeny generated by mating MLC-CAT and MSV-skitransgenic mice displayed higher CAT activity in their muscles than did the MLC-CAT parental line. Identification of gene targets for the fiber-specific action of the c-ski gene product provides a molecular model that could be used for the further dissection of Ski-induced hypertrophy, both in tissue culture and in vivo.

Indexed as

3T3 CellsAnimalsCell LineChloramphenicol O-AcetyltransferaseCreatine KinaseDNA-Binding ProteinsEnhancer Elements, GeneticEnzyme ActivationGene Expression RegulationMiceMice, TransgenicMuscle Fibers, Fast-TwitchMyoD ProteinMyosinsProto-Oncogene ProteinsProto-OncogenesChloramphenicol O-AcetyltransferaseCreatine KinaseDNA-Binding ProteinsMyoD ProteinMyosinsProto-Oncogene ProteinsRNA, MessengerSki protein, mouse

Identifiers

PMID7659522
PMCPMC307140
OpenAlexW2004594025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.